Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Hikma Pharmaceuticals Ord Shs HKMPF

Healthcare
Hikma Pharmaceuticals PLC is a pharmaceutical company. The principal activities of the Company are the development, manufacture and marketing of a range of generic, branded and in-licensed pharmaceutical products. The Company operates through three segments: Injectables, Branded and Generics. The Injectables segment supplies hospitals across its markets with generic injectable products... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (OTCPK:HKMPF)

Hikma marks two-year anniversary of KLOXXADO® launch by surpassing 375,000 doses donated in the US

PR Newswire October 3, 2023

Hikma confirms that it has not signed a licensing agreement with Opiant Pharmaceuticals

PR Newswire April 29, 2022

Hikma Ventures invests in Tact.ai, an AI-powered customer engagement platform for life sciences companies

PR Newswire March 29, 2022

Hikma announces US launch of KLOXXADO(TM) (naloxone HCl) nasal spray 8mg

PR Newswire August 4, 2021

Melinta Therapeutics and Hikma Sign Exclusive Licensing Agreement for Two Novel Anti-Infectives for the Middle East and North Africa Region

Business Wire April 29, 2021

Hikma resumes launch of generic Advair Diskus®

PR Newswire April 20, 2021

Sesen Bio Announces Partnership with Hikma Pharmaceuticals for the Commercialization of Vicineum(TM) in the Middle East and North Africa

Business Wire December 1, 2020

Hikma and Arecor Expand Collaboration

GlobeNewswire October 20, 2020

Hikma receives favourable court ruling for its generic Vascepa®

PR Newswire September 3, 2020
View More News ››

Opinion & Analysis (OTCPK:HKMPF)

No current opinion is available.
View More Opinion ››

Bullboard Posts (OTCPK:HKMPF)

Opioids Market Size, Share, Trends and Forecast 2022-2027

According to IMARC Group’s latest report, titled “Opioids Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast...
edwardebreen15 - August 23, 2022
View more Bullboard ››

Sparta Capital Ltd.

Sparta Capital Ltd.

Sparta Capital Ltd. is a technology-based company. The Company is focused on integrating emerging technologies. The Company ...
View More »